Inogen, Inc. (INGN)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Development, Manufacturing, Marketing, Sales, and Rental of Respiratory Products	348.67M	335.71M	315.66M	377.24M	358.00M
Development, Manufacturing, Marketing, Sales, and Rental of Respiratory Products Growth	3.86%	6.35%	-16.32%	5.37%	16.05%
Total	348.67M	335.71M	315.66M	377.24M	358.00M
Total Growth	3.86%	6.35%	-16.32%	5.37%	16.05%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	209.84M	218.50M	226.26M	276.08M	278.54M
United States Growth	-3.96%	-3.43%	-18.05%	-0.88%	13.07%
Other International	20.82M	17.58M	-	-	-
Other International Growth	18.45%	-	-	-	-
Europe	118.00M	99.63M	-	-	-
Europe Growth	18.45%	-	-	-	-
International	-	-	89.40M	101.16M	79.46M
International Growth	-	-	-11.63%	27.31%	27.86%
Total	348.67M	335.71M	315.66M	377.24M	358.00M
Total Growth	3.86%	6.35%	-16.32%	5.37%	16.05%

Data Source: S&P Global Market Intelligence Last updated: Feb 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error